Latest Insider Transactions at Vor Biopharma Inc. (VOR)
This section provides a real-time view of insider transactions for Vor Biopharma Inc. (VOR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vor Biopharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vor Biopharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 06
2023
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.9%
|
$999
$1.82 P/Share
|
|
Nov 06
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.57%
|
$834
$1.82 P/Share
|
|
Nov 06
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.35%
|
$2,361
$1.82 P/Share
|
|
Sep 01
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-3.97%
|
$11,152
$2.67 P/Share
|
|
Sep 01
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,310
-4.13%
|
$12,620
$2.67 P/Share
|
|
Sep 01
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.82%
|
$25,314
$2.67 P/Share
|
|
Aug 07
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.54%
|
$1,668
$2.67 P/Share
|
|
Aug 07
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.62%
|
$1,750
$2.67 P/Share
|
|
Aug 07
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.34%
|
$4,722
$2.67 P/Share
|
|
Aug 07
2023
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.87%
|
$1,998
$2.67 P/Share
|
|
May 08
2023
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
969
-1.78%
|
$3,876
$4.14 P/Share
|
|
May 08
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.54%
|
$3,336
$4.14 P/Share
|
|
May 08
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.62%
|
$3,500
$4.14 P/Share
|
|
May 08
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.34%
|
$9,444
$4.14 P/Share
|
|
Mar 01
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.77%
|
$63,285
$5.51 P/Share
|
|
Mar 01
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,310
-3.92%
|
$31,550
$5.51 P/Share
|
|
Mar 01
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-3.77%
|
$27,880
$5.51 P/Share
|
|
Feb 06
2023
|
Robert Ang PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
128,750
+15.29%
|
-
|
|
Feb 06
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
45,500
+22.06%
|
-
|
|
Feb 06
2023
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
54,500
+50.0%
|
-
|
|
Feb 06
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
47,750
+24.43%
|
-
|
|
Dec 09
2022
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
11,627,907
+35.72%
|
$46,511,628
$4.3 P/Share
|
|
Sep 13
2022
|
Robert Ang PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
172,500
+22.79%
|
-
|
|
Sep 01
2022
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
86,000
+42.73%
|
-
|
|
Sep 01
2022
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
76,000
+43.94%
|
-
|
|
Nov 16
2021
|
Kush Parmar Director |
SELL
Open market or private sale
|
Indirect |
330,706
-4.94%
|
$4,960,590
$15.3 P/Share
|
|
Nov 16
2021
|
5 Am Ventures Vi, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
330,706
-4.94%
|
$4,960,590
$15.3 P/Share
|
|
Aug 17
2021
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
17,446
+45.4%
|
$17,446
$1.36 P/Share
|
|
Apr 01
2021
|
Ra Capital Management, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
998,382
+26.38%
|
$42,930,426
$43.1 P/Share
|
|
Feb 09
2021
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Conversion of derivative security
|
Direct |
3,534
+50.0%
|
-
|
|
Feb 09
2021
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
BUY
Conversion of derivative security
|
Direct |
3,534
+10.77%
|
-
|
|
Feb 09
2021
|
5 Am Ventures Vi, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
555,555
+10.77%
|
$9,999,990
$18.0 P/Share
|
|
Feb 09
2021
|
5 Am Ventures Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,136,874
+41.01%
|
-
|
|
Feb 09
2021
|
Alexandria Venture Investments, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
282,804
+50.0%
|
-
|
|
Feb 09
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,979,566
+16.13%
|
$53,632,188
$18.0 P/Share
|
|
Feb 09
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
7,143,025
+46.62%
|
-
|
|
Feb 09
2021
|
Kush Parmar Director |
BUY
Open market or private purchase
|
Indirect |
555,555
+10.77%
|
$9,999,990
$18.0 P/Share
|
|
Feb 09
2021
|
Kush Parmar Director |
BUY
Conversion of derivative security
|
Indirect |
6,136,874
+41.01%
|
-
|